Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer

• Lidia Cerquetti,
• Barbara Bucci,
• Salvatore Raffa,
• Donatella Amendola,
• Roberta Maggio,
• Pina Lardo,
• Elisa Petrangeli,
• Maria Rosaria Torrisi,
• Vincenzo Toscano,
• Giuseppe Pugliese,
• Antonio Stigliano

Affiliations

Lidia Cerquetti

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Barbara Bucci

Clinic Pathology Unit, San Pietro Hospital Fatebenefratelli, Rome, Italy

Salvatore Raffa

Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Donatella Amendola

Clinic Pathology Unit, San Pietro Hospital Fatebenefratelli, Rome, Italy

Roberta Maggio

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Pina Lardo

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Elisa Petrangeli

Department of Molecular Medicine Rome, Sapienza University of Rome, Rome, Italy

Maria Rosaria Torrisi

Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Vincenzo Toscano

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Giuseppe Pugliese

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy

Antonio Stigliano

Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital Rome, Sapienza University of Rome, Rome, Italy